caprylates has been researched along with ly2109761 in 1 studies
| Studies (caprylates) | Trials (caprylates) | Recent Studies (post-2010) (caprylates) | Studies (ly2109761) | Trials (ly2109761) | Recent Studies (post-2010) (ly2109761) |
|---|---|---|---|---|---|
| 5,061 | 100 | 2,339 | 65 | 0 | 52 |
| Protein | Taxonomy | caprylates (IC50) | ly2109761 (IC50) |
|---|---|---|---|
| TGF-beta receptor type-1 | Homo sapiens (human) | 0.1279 | |
| TGF-beta receptor type-2 | Homo sapiens (human) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, K; Fetse, JP; Jain, A; Li, Y; Lin, CY; Liu, H; Zhao, Z | 1 |
1 other study(ies) available for caprylates and ly2109761
| Article | Year |
|---|---|
Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
Topics: Animals; Caprylates; Cell Line, Tumor; Cell Proliferation; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Nanoparticles; Pancreatic Neoplasms; Pancreatic Stellate Cells; Pyrazoles; Pyrroles; Stromal Cells; Sulfides; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |